Healthcare and Medical/

Proton Pump Inhibitors is fastest growing segment fueling the growth of Proton Pump Inhibitors Market

naufan

Proton Pump Inhibitors is fastest growing segment fueling the growth of Proton Pump Inhibitors Market

Market Overview:

Proton pump inhibitors are a class of medications used to reduce gastric acid production in the treatment of gastric and duodenal ulcers, gastroesophageal reflux disease, and other conditions. They provide effective relief from heartburn and acid reflux by blocking the action of gastric acid pumps in the stomach wall.

The proton pump inhibitors market is estimated to be valued at US$ 3.29 Bn in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends in the proton pump inhibitors market is the increasing preference for over-the-counter (OTC) drugs over prescription drugs. Proton pump inhibitors like omeprazole, pantoprazole, and lansoprazole are now available without a prescription in most countries, allowing customers to choose OTC options for occasional acidity or heartburn relief instead of relying solely on prescription drugs. This has boosted the growth of the market by improving accessibility of these drugs.

Segment Analysis

The global Proton Pump Inhibitors market is dominated by the omeprazole sub-segment. Omeprazole accounts for over 30% of the global market share owing to its high efficacy in treating conditions like acid reflux and peptic ulcers. It is prescribed widely for conditions requiring long-term treatment with PPIs.

Key Takeaways

The Global Proton Pump Inhibitors Market Size is expected to witness high growth, exhibiting CAGR of 4.3% over the forecast period, due to increasing prevalence of acid reflux diseases and peptic ulcers.

Regional analysis

North America accounts for the largest share in the global PPI market owing to high awareness regarding acid reflux diseases and availability of advanced healthcare facilities. Asia Pacific is expected to grow at the fastest pace during the forecast period due to increase in healthcare expenditure and growth in the medical tourism industry in the region.

Key players

Key players operating in the Proton Pump Inhibitors market are AstraZeneca PLC, Bayer AG, Pfizer Inc., Cadila Pharmaceuticals Limited, Eisai Pharmaceuticals India Pvt. Ltd, Santarus, Inc., Wyeth, LLC, Janssen Pharmaceutica, Takeda Pharmaceutical Company Limited, Sanofi S.A, Aurobindo Pharma, Perrigo Company plc, Dr. Reddy's Laboratories, Aralez Pharmaceuticals Inc., RedHill Biopharma Ltd and Cipla Limited.

Get more insights on this topic:

https://www.dailyprbulletin.com/proton-pump-inhibitors-market-size-share/

naufan

Proton Pump Inhibitors Market is Estimated to Witness High Growth Owing to Increase in Gastrointestinal Problems

Purvaja 2024-02-07

The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3. Rise in the risk factors that cause gastrointestinal problems such as smoking, excess alcohol consumption and use of anti-inflammatory drugs are driving the growth of the proton pump inhibitors market. SWOT Analysis Strength: Proton pump inhibitors have gained wide acceptance for use in treating acid-related gastrointestinal disorders owing to their effectiveness. Key Takeaways The Global Proton Pump Inhibitors Market Share is expected to witness high growth over the forecast period. The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3. The key players operating in the proton pump inhibitors market are Horizon Therapeutics plc, Ammonett Pharma LLC, Medison Pharma Ltd.

Global Proton Pump Inhibitors Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Gastroesophageal Reflux Disease (GERD)

Pooja salve 2023-08-18

The global Proton Pump Inhibitors Market is estimated to be valued at US$ 2. A) Market Overview: Proton pump inhibitors (PPIs) are a class of drugs used to reduce the production of stomach acid. B) Market Key Trends: One key trend in the global Proton Pump Inhibitors Market is the increasing prevalence of gastroesophageal reflux disease (GERD). Economic: The global Proton Pump Inhibitors Market is driven by the increasing healthcare expenditure and rising prevalence of GERD worldwide. In conclusion, the global Proton Pump Inhibitors Market is expected to witness significant growth over the forecast period.

Proton Pump Inhibitors is Fueling the Growth of Global Proton Pump Inhibitors Market

Poonam 2023-11-29

The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3. They are commonly used for conditions like acid reflux, ulcers and heartburn. New product launches by key players with formulations enabling once-a-day dosing have further boosted the adoption of proton pump inhibitors for management of acid reflux and ulcers. Segment Analysis The global proton pump inhibitors market is dominated by the omeprazole sub-segment owing to its significant popularity as an effective treatment option for acid reflux and heartburn. Regional analysis North America currently dominates the global proton pump inhibitors market due to high awareness levels about acid reflux diseases and rising obese population.

Proton Pump Inhibitors Market - Global Outlook and Forecast 2021-2027

sanavi desai 2021-08-26

Proton Pump Inhibitors Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Proton Pump Inhibitors Market Sales, 2016-2021, 2022-2027, (M Units) Global top five Proton Pump Inhibitors companies in 2020 (%)The global Proton Pump Inhibitors market was valued at 13180 million in 2020 and is projected to reach US$ 11640 million by 2027, at a CAGR of -3.1% during the forecast period.We Surveyed the Proton Pump Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6548508/global-proton-pump-inhibitors-2021-2027-594Total Market by Segment:Global Proton Pump Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)Global Proton Pump Inhibitors Market Segment Percentages, By Type, 2020 (%)DexlansoprazoleEsomeprazoleLansoprazoleOmeprazolePantoprazoleRabeprazoleGlobal Proton Pump Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)Global Proton Pump Inhibitors Market Segment Percentages, By Application, 2020 (%)Hospital PharmacyRetail PharmacyOthersGlobal Proton Pump Inhibitors Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Units)Global Proton Pump Inhibitors Market Segment Percentages, By Region and Country, 2020 (%)North AmericaUSCanadaMexicoEuropeGermanyFranceU.K.ItalyRussiaNordic CountriesBeneluxRest of EuropeAsiaChinaJapanSouth KoreaSoutheast AsiaIndiaRest of AsiaSouth AmericaBrazilArgentinaRest of South AmericaMiddle East & AfricaTurkeyIsraelSaudi ArabiaUAERest of Middle East & AfricaCompetitor AnalysisThe report also provides analysis of leading market participants including:Key companies Proton Pump Inhibitors revenues in global market, 2016-2021 (Estimated), ($ millions)Key companies Proton Pump Inhibitors revenues share in global market, 2020 (%)Key companies Proton Pump Inhibitors sales in global market, 2016-2021 (Estimated), (M Units)Key companies Proton Pump Inhibitors sales share in global market, 2020 (%)Further, the report presents profiles of competitors in the market, key players include:TakedaPfizerAstraZenecaBayerSun PharmaTevaEisai Co.MylanAOSAIKANG PharmaLuoxin PharmaLIVZONEastchina PharmaReasons to Purchase Our Research Report:1.

Analyzing the outlook of the market with the recent trends and SWOT analysis2.

Market dynamics scenario, along with growth opportunities of the market in the years to come3.

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects4.

Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.5.

Market value (USD Million) and volume (Units Million) data for each segment and sub-segment6.

Proton Pump Inhibitors Market: Increasing Prevalence of Gastroesophageal Reflux Disease Driving Growth

Gauri Cmi 2023-10-10

The global proton pump inhibitors market is estimated to be valued at US$2. The growing need to manage GERD and other acid-related disorders is driving the demand for proton pump inhibitors globally. The bargaining power of buyers in the proton pump inhibitors market is expected to be moderate. In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the proton pump inhibitors market. In conclusion, the proton pump inhibitors market is expected to witness substantial growth due to increasing prevalence of acid-related disorders and a growing geriatric population.

Exploring The Link Between Proton Pump Inhibitors And Osteoporosis

sachin sadgir 2023-08-01

However, recent studies have raised concerns about their potential link to osteoporosis, a condition characterized by weakened bones. some studies suggest that long-term PPI use may interfere with calcium absorption, which is essential for maintaining bone density. Over time, this can lead to an increased risk of fractures, especially in older individuals who are already at a higher risk of osteoporosis. If you are on long-term Proton Pump Inhibitors therapy, your doctor may recommend regular bone density assessments and supplementation with calcium and vitamin D to mitigate the risk of osteoporosis. It's crucial to remember that the benefits of PPIs in managing acid reflux often outweigh the potential risks.

WHO TO FOLLOW